Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-010030
Filing Date
2020-04-24
Accepted
2020-04-24 14:29:33
Documents
2
Period of Report
2020-04-24

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea121042-6k_tizianalife.htm 6-K 14332
2 REGULATORY NEWS SERVICE ANNOUNCEMENT, DATED APRIL 24, 2020 ea121042ex99-1_tiziana.htm EX-99.1 18125
  Complete submission text file 0001213900-20-010030.txt   33489
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Filer) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 20814471
SIC: 2834 Pharmaceutical Preparations